Clinical Trials Directory

Trials / Completed

CompletedNCT01499641

Epidural Steroid Following Discectomy for Herniated Disc Reduces Morbidity

Epidural Steroid Following Discectomy for Herniated Lumbar Disc Reduces Neurological Impairment and Enhances Recovery. A Randomized Study With Two-year Follow-up

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
200 (actual)
Sponsor
Northern Orthopaedic Division, Denmark · Academic / Other
Sex
All
Age
18 Years – 66 Years
Healthy volunteers
Not accepted

Summary

Focus of this study is evaluation of the outcome, neurologic impairment and safety of epidural steroide following lumbar discectomy for herniated disc disease.

Detailed description

Methylprednisolone might enhance recovery after discectomy for herniated disc disease without apparent side effect. Convalescence after discectomy for herniated disc disease is dependent on pain and the inflammatory response. In arthroscopic and abdominal surgery steroids reduce the inflammatory response and enhance recovery. 200 patients with herniated disc disease are randomly allocated to receive epidural methylprednisolone 40 mg or none.

Conditions

Interventions

TypeNameDescription
DRUGMethylprednisoloneEpidural methylprednisolone 40 mg or none

Timeline

Start date
2001-05-01
Primary completion
2003-08-01
Completion
2005-12-01
First posted
2011-12-26
Last updated
2014-09-15

Locations

3 sites across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01499641. Inclusion in this directory is not an endorsement.